CN Patent

CN106038538A — 一种右美托咪定的预混合制剂

Assigned to Jiangsu Hengrui Medicine Co Ltd · Expires 2016-10-26 · 10y expired

What this patent protects

本发明涉及一种右美托咪定的预混合制剂。具体而言，本发明涉及包装在含有塑料的容器中右美托咪定或其药学上可接受的盐的即用型预混合(premixed,ready to use)制剂，其可以用于重症监护病房(ICU)病患的镇静和操作时的镇静(Procedural Sedation)。

USPTO Abstract

本发明涉及一种右美托咪定的预混合制剂。具体而言，本发明涉及包装在含有塑料的容器中右美托咪定或其药学上可接受的盐的即用型预混合(premixed,ready to use)制剂，其可以用于重症监护病房(ICU)病患的镇静和操作时的镇静(Procedural Sedation)。

Drugs covered by this patent

Patent Metadata

Patent number
CN106038538A
Jurisdiction
CN
Classification
—
Expires
2016-10-26
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Hengrui Medicine Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.